Tradestie Institutional Equity Comparison Engine

CREVW vs CDIOW โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CDIOW Overall Edge

CDIOW Captures Institutional Edge (1โ€“0 Pillars ยท 2โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Cardio Diagnostics Holdings Inc. Warrant (CDIOW) driven by superior Momentum & Technical. Fundamentally, CREVW trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus CDIOW at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, CREVW sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CDIOW sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
CREVW N/M vs CDIOW N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner CDIOW
1Y -89.8% vs -58.7% ยท 52W Pos 0% vs 1%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
CREVW NASDAQ
Carbon Revolution Public Limited Company Warrant
Institutional Equity
$0.00
-58.82% 1D
Market Cap N/A
1M Return -71.54%
1Y Return -89.8%
Forward P/E N/M
Unified AI Score
39.1 / 100 SELL
Tech 45.0 Fund 51.0 Flow 50.0 Mom 60.0
CDIOW NASDAQ
Cardio Diagnostics Holdings Inc. Warrant
In Vitro & In Vivo Diagnostic Substances
$0.01
-38.54% 1D
Market Cap N/A
1M Return -41.0%
1Y Return -58.74%
Forward P/E N/M
Unified AI Score
35.2 / 100 SELL
Tech 15.0 Fund 33.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CREVW -89.8% CDIOW -58.74% Spread: +112.66 pp (CDIOW Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CREVW TTM Op. Margin: N/A CDIOW TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CREVW vs CDIOW. Trailing 12-month operating profitability (CREVW N/A vs CDIOW N/A) and valuation multiples (CREVW N/M vs CDIOW N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CREVW (1) vs CDIOW (2)
Institutional Metric CREVW CDIOW Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 0% ($0โ€“$0) 1% ($0โ€“$0) Stronger Trend CDIOW
Beta / 30D Volatility Risk Regime -0.07ฮฒ ยท 354% Vol 1.59ฮฒ ยท 280% Vol Lower Realized Risk CDIOW
Unified Institutional Score Composite Signal 39.1 / 100 (SELL) 35.2 / 100 (SELL) Higher Composite CREVW

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CREVW vs CDIOW Buy Guide
CREVW UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CREVW Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CDIOW UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CDIOW Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CREVW nor CDIOW registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.